BIOMAT Database Logo BIOMAT Database Logo

Therapeutic impact of orthotopic liver transplantation on disorders of hemostasis. 1993

P Fischbach, and I Scharrer
University Hospital Frankfurt Center for Internal Medicine, Department of Angiology, Germany.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic

Related Publications

P Fischbach, and I Scharrer
[Disorders of hemostasis in orthotopic liver transplantation in an experiment].
January 1995, Patologicheskaia fiziologiia i eksperimental'naia terapiia,
P Fischbach, and I Scharrer
Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
January 1993, Seminars in thrombosis and hemostasis,
P Fischbach, and I Scharrer
Role of leukocytes in hemostasis during orthotopic liver transplantation.
January 1993, Seminars in thrombosis and hemostasis,
P Fischbach, and I Scharrer
[Coagulation disorders during orthotopic liver transplantation].
June 1989, Nihon Geka Gakkai zasshi,
P Fischbach, and I Scharrer
Orthotopic liver transplantation in liver-based metabolic disorders.
January 1992, European journal of pediatrics,
P Fischbach, and I Scharrer
Impact of orthotopic liver transplantation on mortality from pediatric liver disease.
April 1991, Journal of pediatric gastroenterology and nutrition,
P Fischbach, and I Scharrer
Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
January 1993, Seminars in thrombosis and hemostasis,
P Fischbach, and I Scharrer
Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
January 1993, Seminars in thrombosis and hemostasis,
P Fischbach, and I Scharrer
Impact of donor infections on outcome of orthotopic liver transplantation.
May 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
P Fischbach, and I Scharrer
Impact of transjugular intrahepatic portosystemic shunt on orthotopic liver transplantation.
January 1994, World journal of surgery,
Copied contents to your clipboard!